|
|
Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary
Marine Huin
,
Jerome Lorenzini
,
Flavie Arbion
,
Xavier Carcopino
,
Cyril Touboul
,
et al.
Journal articles
hal-03886170v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Tenue vestimentaire au bloc opératoire 2021
El-Mahdi Hafiani
,
Pierre Cassier
,
Serge Aho
,
Pierre Albaladejo
,
Hélène Beloeil
,
et al.
Journal articles
hal-04148871v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial
Philippe Merle
,
Jean-Frédéric Blanc
,
Julien Edeline
,
Karine Le Malicot
,
Manon Allaire
,
et al.
Journal articles
hal-04016442v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study
Côme Lepage
,
J-M. Phelip
,
Astrid Lièvre
,
Karine Le Malicot
,
L Dahan
,
et al.
Journal articles
hal-03810530v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
G.S. Roth
,
C. Neuzillet
,
M. Sarabi
,
J. Edeline
,
D Malka
,
et al.
Journal articles
hal-03931293v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
Cyrille Féray
,
Loic Campion
,
Philippe Mathurin
,
Isabelle Archambreaud
,
Xavier Mirabel
,
et al.
Journal articles
hal-04044132v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric study
Alexandre Bourdiol
,
Vincent Legros
,
Fanny Vardon-Bounes
,
Thomas Rimmele
,
Paul Abraham
,
et al.
Journal articles
hal-04141716v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Challenges in glioblastoma research: focus on the tumor microenvironment
Andreas Bikfalvi
,
Cristine Alves da Costa
,
Tony Avril
,
Jean-Vianney Barnier
,
Luc Bauchet
,
et al.
Journal articles
hal-03860005v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The hexosamine pathway and coat complex II promote malignant adaptation to nutrient scarcity
Helena Dragic
,
Audrey Barthelaix
,
Cédric Duret
,
Simon Le Goupil
,
Hadrien Laprade
,
et al.
Journal articles
hal-03660129v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018
Olivier Bylicki
,
Pascale Tomasini
,
Gervais Radj
,
Florian Guisier
,
Isabelle Monnet
,
et al.
Journal articles
hal-04016683v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Guidelines for clothing in the operating theatre, 2021
El-Mahdi Hafiani
,
Pierre Cassier
,
Serge Aho
,
Pierre Albaladejo
,
Hélène Beloeil
,
et al.
Journal articles
hal-03690335v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
Véronique Vendrely
,
Claire Lemanski
,
Pascal Pommier
,
Karine Le Malicot
,
Angélique Saint
,
et al.
Journal articles
hal-04016479v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response
Adriana Martinez-Turtos
,
Rachel Paul
,
Manuel Grima-Reyes
,
Hussein Issaoui
,
Adrien Krug
,
et al.
Journal articles
inserm-03773747v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|